Narsete T, Ansfield F, Wirtanen G, Ramirez G, Wolberg W, Jarrett F
Ann Surg. 1977 Dec;186(6):734-6. doi: 10.1097/00000658-197712000-00012.
Gastric ulceration developed in eight patients during intrahpeatic arterial infusion of 5-FU. Bleeding occurred in four instances and perforation in one. In all cases the catheter tip had been dislodged and was proximal to its correct position, allowing the stomach to be directly infused with 5-FU. No duodenal ulcers were noted. All patients were symptomatic for several days before the diagnosis was made. Of 20 patients with catheter dislodgement, five had documented ulcers, three had upper gastrointestinal bleeding of undetermined etiology, eight had epigastric pain or vomiting and only four were asymptomatic. Prompt determination of catheter position is necessary in patients receiving intrahepatic arterial infusion of 5-FU if symptoms consistent with gastric ulceration occur. Gastric ulcers should be vigorously treated because of the high rate of complications in patients receiving chemotherapy.
8例患者在肝动脉内输注5-氟尿嘧啶(5-FU)期间发生胃溃疡。4例出现出血,1例发生穿孔。所有病例中,导管尖端均已移位,位于正确位置近端,致使胃直接被输注了5-FU。未发现十二指肠溃疡。所有患者在确诊前均有几天出现症状。在20例导管移位的患者中,5例有记录在案的溃疡,3例有病因不明的上消化道出血,8例有上腹部疼痛或呕吐,只有4例无症状。如果接受肝动脉内输注5-FU的患者出现与胃溃疡相符的症状,必须迅速确定导管位置。由于接受化疗的患者并发症发生率高,胃溃疡应积极治疗。